Potent phagocytic activity with impaired antigen presentation identifying lipopolysaccharide-tolerant human monocytes: Demonstration in isolated monocytes from cystic fibrosis patients

Journal of Immunology

Volumn 182, Issue 10, 2009, Pages 6494-6507

  Del Fresno, Carlos ^a   García Rio, Francisco ^a   Gómez Piña, Vanesa ^a   Soares Schanoski, Alessandra ^a   Fernández Ruíz, Irene ^a   Jurado, Teresa ^a   Kajiji, Tasneem ^b   Shu, Chen ^b   Marín, Elvira ^c   Del Arroyo, Ana Gutierrez ^d   Prados, Concepción ^a   Arnalich, Francisco ^e   Fuentes Prior, Pablo ^f   Biswas, Subrha K ^b   López Collazo, Eduardo ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b AGENCY FOR SCIENCE   (Singapore)

^c Discovery Unit   (Spain)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^f HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CD64 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE; SALMONELLA ENDOTOXIN; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1;

ADULT; ANTIGEN PRESENTATION; ARTICLE; CELL CULTURE; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; CYTOKINE PRODUCTION; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOLOGICAL TOLERANCE; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MONOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PHAGOCYTOSIS; PHENOTYPE; PRIORITY JOURNAL;

ADULT; ANTIGEN PRESENTATION; CYSTIC FIBROSIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HUMANS; IMMUNE TOLERANCE; INTERLEUKIN-10; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MALE; MONOCYTES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHAGOCYTOSIS; POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77952395705     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0803350     Document Type: Article

References (66)

1. Beeson, P. 1946. Development of tolerance to typhoid bacterial pyrogen and its abolition by reticulo-endothelial blockade. Proc. Soc. Exp. Biol. Med. 61: 248-250.
2. Cavaillon, J. M., and M. Adib-Conquy. 2006. Bench-to-bedside review: endotoxin tolerance as a model of leukocyte reprogramming in sepsis. Crit. Care 10: 233.
3. Freudenberg, M. A., and C. Galanos. 1988. Induction of tolerance to lipopolysaccharide (LPS)-D-galactosamine lethality by pretreatment with LPS is mediated by macrophages. Infect. Immun. 56: 1352-1357.
4. Broad, A., D. E. Jones, and J. A. Kirby. 2006. Toll-like receptor (TLR) response tolerance: a key physiological "damage limitation" effect and an important potential opportunity for therapy. Curr. Med. Chem. 13: 2487-2502.
5. Granowitz, E. V., R. Porat, J. W. Mier, S. F. Orencole, G. Kaplanski, E. A. Lynch, K. Ye, E. Vannier, S. M. Wolff, and C. A. Dinarello. 1993. Intravenous endotoxin suppresses the cytokine response of peripheral blood mononuclear cells of healthy humans. J. Immunol. 151: 1637-1645. (Pubitemid 23219302)
6. Faas, M. M., H. Moes, J. W. Fijen, A. C. Muller Kobold, J. E. Tulleken, and J. G. Zijlstra. 2002. Monocyte intracellular cytokine production during human endotoxaemia with or without a second in vitro LPS challenge: effect of RWJ-67657, a p38 MAP-kinase inhibitor, on LPS-hyporesponsiveness. Clin. Exp. Immunol. 127: 337-343.
7. Escoll, P., C. del Fresno, L. García, G. Vallés, M. Lendínez, F. Arnalich, and E. López-Collazo. 2003. Rapid up-regulation of IRAK-M expression following a second endotoxin challenge in human monocytes and in monocytes isolated from septic patients. Biochem. Biophys. Res. Commun. 311: 465-472. (Pubitemid 37340100)
8. del Fresno, C., L. Soler-Rangel, A. Soares-Schanoski, V. Gómez-Piña, M. González-León, L. Gómez- García, E. Mendoza-Barberá, A. Rodríguez-Rojas, F. García, P. Fuentes-Prior, et al. 2007. Inflammatory responses associated with acute coronary síndrome up-regulate IRAK-M and induce endotoxin tolerance in circulating monocytes. J. Endotoxin Res. 13: 39-52. (Pubitemid 47471334)
9. del Fresno, C., V. Gómez-Piña, V. Lores, A. Soares-Schanoski, I. Fernández-Ruiz, B. Rojo, R. Alvarez-Sala, E. Caballero-Garrido, F. García, T. Veliz, et al. 2008. Monocytes from cystic fibrosis patients are locked in an LPS tolerance state: Down-regulation of TREM-1 as putative underlying mechanism. PLoS ONE 3: e2667.
10. Bohrer, H., F. Qiu, T. Zimmermann, Y. Zhang, T. Jllmer, D. Mannel, B. W. Bottiger, D. M. Stern, R. Waldherr, H. D. Saeger, et al. 1997. Role of NFκB in the mortality of sepsis. J. Clin. Invest. 100:972-985.
11. López-Collazo, E., P. Fuentes-Prior, F. Arnalich, and C. del Fresno. 2006. Physiopathology of interleukin-1 receptor-associated kinase M: implications in refractory state. Curr. Opin. Infect. Dis. 19: 237-244. (Pubitemid 43740361)
12. Sly, L. M., M. J. Rauh, J. Kalesnikoff, C. H. Song, and G. Krystal. 2004. LPS-induced upregulation of SHIP is essential for endotoxin tolerance. Immunity 21: 227-239.
13. Zhong, B., H. Y. Ma, Q. Yang, F. R. Gu, G. Q. Yin, and C. M. Xia. 2008. Decrease in Toll-like receptors 2 and 4 in the spleen of mouse with endotoxic tolerance. Inflamm. Res. 20: 36-45.
14. Jiang, W., R. Sun, H. Wei, and Z. Tian. 2005. Toll-like receptor 3 ligand attenuates LPS-induced liver injury by down-regulation of Toll-like receptor 4 expression on macrophages. Proc. Natl. Acad. Sci. USA 102: 17077-17082. (Pubitemid 41692686)
15. Li, C. H., J. H. Wang, and H. P. Redmond. 2006. Bacterial lipoprotein-induced self-tolerance and cross-tolerance to LPS are associated with reduced IRAK-1 expression and MyD88-IRAK complex formation. J. Leukocyte Biol. 79: 867-875.
16. Medvedev, A. E., A. Lentschat, L. M. Wahl, D. T. Golenbock, and S. N. Vogel. 2002. Dysregulation of LPS-induced Toll-like receptor 4-MyD88 complex formation and IL-1 receptor-associated kinase 1 activation in endotoxin-tolerant cells. J. Immunol. 169: 5209-5216.
17. van 't Veer, C., P. S. van den Pangaart, M. A. van Zoelen, M. de Kruif, R. S. Birjmohun, E. S. Stroes, A. F. de Vos, and T. van der Poll. 2007. Induction of IRAK-M is associated with lipopolysaccharide tolerance in a human endotoxemia model. J. Immunol. 179: 7110-7120.
18. Kobayashi, K., L. D. Hernandez, J. E. Galan, C. A. Janeway, Jr., R. Medzhitov, and R. A. Flavell. 2002. IRAK-M is a negative regulator of Toll-like receptor signaling. Cell 110: 191-202. (Pubitemid 34876547)
19. Flohe, S., E. Dominguez Fernandez, M. Ackermann, T. Hirsch, J. Borgermann, and F. U. Schade. 1999. Endotoxin tolerance in rats: expression of TNF-α, IL-6, IL-10, VCAM-1, and HSP70 in lung and liver during endotoxin shock. Cytokine 11: 796-804. (Pubitemid 29460479)
20. Randow, F., U. Syrbe, C. Meisel, D. Krausch, H. Zuckermann, C. Platzer, and H. D. Volk. 1995. Mechanism of endotoxin desensitization: involvement of interleukin 10 and transforming growth factor beta. J. Exp. Med. 181: 1887-1892.
21. Foster, S. L., D. C. Hargreaves, and R. Medzhitov. 2007. Gene-specific control of inflammation by TLR-induced chromatin modifications. Nature 447: 972-978.
22. Biswas, S. K., L. Gangi, S. Paul, T. Schioppa, A. Saccani, M. Sironi, B. Bottazzi, A. Doni, B. Vincenzo, F. Pasqualini, et al. 2006. A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-κB and enhanced IRF-3/STAT1 activation). Blood 107: 2112-2122.
23. Sica, A., P. Larghi, A. Mancino, L. Rubino, C. Porta, M. G. Totaro, M. Rimoldi, S. K. Biswas, P. Allavena, and A. Mantovani. 2008. Macrophage polarization in tumour progression. Semin. Cancer Biol. 2008: 65-75.
24. Deepak, P., S. Kumar, and A. Acharya. 2007. Interleukin-13-induced type II polarization of inflammatory macrophages is mediated through suppression of nuclear factor-κB and preservation of IκBα in a T cell lymphoma. Clin. Exp. Immunol. 149: 378-386. (Pubitemid 47063061)
25. Grage-Griebenow, E., H. D. Flad, M. Ernst, M. Bzowska, J. Skrzeczynska, and J. Pryjma. 2000. Human MO subsets as defined by expression of CD64 and CD16 differ in phagocytic activity and generation of oxygen intermediates. Immunobiology 202: 42-50. (Pubitemid 30323615)
26. Ioan-Facsinay, A., S. J. de Kimpe, S. M. Hellwig, P. L. van Lent, F. M. Hofhuis, H. H. van Ojik, C. Sedlik, S. A. da Silveira, J. Gerber, Y. F. de Jong, et al. 2002. Fc RI (CD64) contributes substantially to severity of arthritis, hypersensitivity responses, and protection from bacterial infection. Immunity 16: 391-402. (Pubitemid 34260917)
27. Miller, M. R., J. Hankinson, V. Brusasco, F. Burgo, R. Casaburi, A. Coates, R. Crapo, P. Enright, C. P. van der Grinten, P. Gustafsson, et al. 2007. Standardisation of spirometry (in French). Rev. Mal. Respir. 24: 2S27-2S49.
28. Quanjer, P. H., G. J. Tammeling, J. E. Cotes, O. F. Pedersen, R. Peslin, and J. C. Yernault. 1993. Lung volumes and forced ventilatory flows: Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal: Official Statement of the European Respiratory Society. Eur. Respir. J. 16(Suppl.): 5-40.
29. del Fresno, C., K. Otero, L. Gómez-García, M. González-León, L. Soler-Ranger, P. Fuentes-Prior, P. Escoll, R. Baos, L. Caveda, F. García, et al. 2005. Tumor cells deactivate human monocytes by up-regulating IL-1 receptor associated kinase-M expression via CD44 and TLR4. J. Immunol. 174: 3032-3040.
30. Gomez-Pina, V., A. Soares-Schanoski, A. Rodriguez-Rojas, C. Del Fresno, F. Garcia, M. T. Vallejo-Cremades, I. Fernandez-Ruiz, F. Arnalich, P. Fuentes-Prior, and E. Lopez-Collazo. 2007. Metalloproteinases shed TREM-1 ectodomain from lipopolysaccharide-stimulated human monocytes. J. Immunol. 179: 4065-4073.
31. de las Heras, B., S. Hortelano, N. Giron, P. Bermejo, B. Rodriguez, and L. Bosca. 2007. Kaurane diterpenes protect against apoptosis and inhibition of phagocytosis in activated macrophages. Br. J. Pharmacol. 152: 249-255.
32. Pinheiro da Silva, F., M. Aloulou, D. Skurnik, M. Benhamou, A. Andremont, I. T. Velasco, M. Chiamolera, J. S. Verbeek, P. Launay, and R. C. Monteiro. 2007. CD16 promotes Escherichia coli sepsis through an FcRγ inhibitory pathway that prevents phagocytosis and facilitates inflammation. Nat. Med. 13: 1368-1374.
33. Hernandez-Fuentes, M. P., A. N. Warrens, and R. I. Lechler. 2003. Immunologic monitoring. Immunol. Rev. 196: 247-264.
34. Adams, A. B., T. C. Pearson, and C. P. Larsen. 2003. Heterologous immunity: an overlooked barrier to tolerance. Immunol. Rev. 196: 147-160.
35. Yoza, B. K., J. Y. Hu, S. L. Cousart, L. M. Forrest, and C. E. McCall. 2006. Induction of RelB participates in endotoxin tolerance. J. Immunol. 177: 4080-4085. (Pubitemid 44359942)
36. Mantovani, A., A. Sica, and M. Locati. 2007. New vistas on macrophage differentiation and activation. Eur. J. Immunol. 37: 14-16. (Pubitemid 46128780)
37. Fukao, T., D. M. Frucht, G. Yap, M. Gadina, J. J. O'Shea, and S. Koyasu. 2001. Inducible expression of Stat4 in dendritic cells and macrophages and its critical role in innate and adaptive immune responses. J. Immunol. 166: 4446-4455. (Pubitemid 32233728)
38. Jacobsen, E. A., S. I. Ochkur, R. S. Pero, A. G. Taranova, C. A. Protheroe, D. C. Colbert, N. A. Lee, and J. J. Lee. 2008. Allergic pulmonary inflammation in mice is dependent on eosinophil-induced recruitment of effector T cells. J. Exp. Med. 205: 699-710.
39. Park-Min, K. H., T. T. Antoniv, and L. B. Ivashkiv. 2005. Regulation of macrophage phenotype by long-term exposure to IL-10. Immunobiology 210: 77-86.
40. Petit-Bertron, A. F., T. Pedron, U. Gross, J. Y. Coppee, P. J. Sansonetti, J. M. Cavaillon, and M. Adib-Conquy. 2005. Adherence modifies the regulation of gene expression induced by interleukin-10. Cytokine 29: 1-12.
41. Antoniv, T. T., K. H. Park-Min, and L. B. Ivashkiv. 2005. Kinetics of IL-10-induced gene expression in human macrophages. Immunobiology 210: 87-95. (Pubitemid 41025149)
42. Antoniv, T. T., and L. B. Ivashkiv. 2006. Dysregulation of interleukin-10-dependent gene expression in rheumatoid arthritis synovial macrophages. Arthritis Rheum. 54: 2711-2721. (Pubitemid 44497750)
43. LeibundGut-Landmann, S., J. M. Waldburger, M. Krawczyk, L. A. Otten, T. Suter, A. Fontana, H. Acha-Orbea, and W. Reith. 2004. Mini-review: specificity and expression of CIITA, the master regulator of MHC class II genes. Eur. J. Immunol. 34: 1513-1525. (Pubitemid 39256032)
44. Guo, R., P. Zou, H. H. Fan, L. Cui, Y. L. Cao, B. Zheng, L. Gao, F. Gao, and H. Z. Lu. 2003. Inhibition effect of CIITA anti-sense cDNA on the expression of MHCII molecules of Hela cells (in Chinese). Zhonghua Xue Ye Xue Za Zhi 24: 636-639.
45. Jabrane-Ferrat, N., N. Nekrep, G. Tosi, L. Esserman, and B. M. Peterlin. 2003. MHC class II enhanceosome: how is the class II transactivator recruited to DNA-bound activators? Int. Immunol. 15: 467-475. (Pubitemid 36432399)
46. Wolk, K., S. Kunz, N. E. Crompton, H. D. Volk, and R. Sabat. 2003. Multiple mechanisms of reduced major histocompatibility complex class II expression in endotoxin tolerance. J. Biol. Chem. 278: 18030-18036. (Pubitemid 36799413)
47. Drozina, G., J. Kohoutek, N. Jabrane-Ferrat, and B. M. Peterlin. 2005. Expression of MHC II genes. Curr. Top. Microbiol. Immunol. 290: 147-170.
48. Baton, F., C. Deruyffelaere, M. Chapin, T. Prod'homme, D. Charron, R. Al-Daccak, and C. Alcaide-Loridan. 2004. Class II transactivator (CIITA) isoform expression and activity in melanoma. Melonoma Res. 14: 453-461.
49. Heagy, W., K. Nieman, C. Hansen, M. Cohen, D. Danielson, and M. A. West. 2003. Lower levels of whole blood LPS-stimulated cytokine release are associated with poorer clinical outcomes in surgical ICU patients. Surg. Infect. (Larchmt) 4: 171-180. (Pubitemid 37038783)
50. Munoz, C., J. Carlet, C. Fitting, B. Misset, J. P. Bleriot, and J. M. Cavaillon. 1991. Dysregulation of in vitro cytokine production by monocytes during sepsis. J. Clin. Invest. 88: 1747-1754.
51. Mantovani, A., S. Sozzani, M. Locati, P. Allavena, and A. Sica. 2002. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 23: 549-555. (Pubitemid 35223554)
52. Tessarz, A. S., and A. Cerwenka. 2008. The TREM-1/DAP12 pathway. Immunol. Lett. 116: 111-116.
53. Xie, Q., L. Gan, J. Wang, I. Wilson, and L. Li. 2007. Loss of the innate immunity negative regulator IRAK-M leads to enhanced host immune defense against tumor growth. Mol. Immunol. 44: 3453-3461.
54. Klesney-Tait, J., I. R. Turnbull, and M. Colonna. 2006. The TREM receptor family and signal integration. Nat. Immunol. 7: 1266-1273. (Pubitemid 46111244)
55. Murphey, E. D., G. Fang, T. K. Varma, and E. R. Sherwood. 2007. Improved bacterial clearance and decreased mortality can be induced by LPS tolerance and is not dependent upon IFN-γ. Shock 27: 289-295. (Pubitemid 46272457)
56. Muthukuru, M., and C. W. Cutler. 2008. Antigen capture of Porphyromonas gingivalis by human macrophages is enhanced but killing and antigen presentation are reduced by endotoxin tolerance. Infect. Immun. 76: 477-485. (Pubitemid 351251717)
57. Monneret, G., A. Lepape, N. Voirin, J. Bohe, F. Venet, A. L. Debard, H. Thizy, J. Bienvenu, F. Gueyffier, and P. Vanhems. 2006. Persisting low monocyte human leukocyte antigen-DR expression predicts mortality in septic shock. Intensive Care Med. 32: 1175-1183. (Pubitemid 44232412)
58. Nakahara, T., Y. Moroi, H. Uchi, and M. Furue. 2006. Differential role of MAPK signaling in human dendritic cell maturation and Th1/Th2 engagement. J. Dermatol. Sci. 42: 1-11. (Pubitemid 43384125)
59. Sibley, C. D., H. Rabin, and M. G. Surette. 2006. Cystic fibrosis: a polymicrobial infectious disease. Future Microbiol. 1: 53-61.
60. Wu, Q., Z. Lu, M. W. Verghese, and S. H. Randell. 2005. Airway epithelial cell tolerance to Pseudomonas aeruginosa. Respir. Res. 6: 26-36. (Pubitemid 41358043)
61. Alexis, N. E., M. S. Muhlebach, D. B. Peden, and T. L. Noah. 2006. Attenuation of host defense function of lung phagocytes in young cystic fibrosis patients. J. Cyst. Fibros. 5: 17-25.
62. Moraes, T. J., J. Plumb, R. Martin, E. Vachon, V. Cherepanov, A. Koh, C. Loeve, J. Jongstra-Bilen, J. H. Zurawska, J. V. Kus, et al. 2006. Abnormalities in the pulmonary innate immune system in cystic fibrosis. Am. J. Respir. Cell Mol. Biol. 34: 364-374.
63. Roghanian, A., E. M. Drost, W. MacNee, S. E. Howie, and J. M. Sallenave. 2006. Inflammatory lung secretions inhibit dendritic cell maturation and function via neutrophil elastase. Am. J. Respir. Crit. Care Med. 174: 1189-1198. (Pubitemid 44924819)
64. Goss, C. H., and J. L. Burns. 2007. Exacerbations in cystic fibrosis, 1: Epidemiology and pathogenesis. Thorax 62: 360-367. (Pubitemid 46580580)
65. Calabrese, F., S. Baraldo, E. Bazzan, F. Lunardi, F. Rea, P. Maestrelli, G. Turato, K. Lokar-Oliani, A. Papi, R. Zuin, et al. 2008. IL-32, a novel proinflammatory cytokine in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 75: 69-79.
66. Koehm, S., R. G. Slavin, P. S. Hutcheson, T. Trejo, C. S. David, and C. J. Bellone. 2007. HLA-DRB1 alleles control allergic bronchopulmonary aspergillosis-like pulmonary responses in humanized transgenic mice. J. Allergy Clin. Immunol. 120: 570-577. (Pubitemid 47320742)